Page last updated: 2024-10-21

hydroxyindoleacetic acid and Carcinoma, Lewis Lung

hydroxyindoleacetic acid has been researched along with Carcinoma, Lewis Lung in 1 studies

(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.

Carcinoma, Lewis Lung: A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, H1
Li, G1
Liu, L1
Guo, Z1
Ma, X1
Cao, N1
Lin, H1
Han, G1
Duan, Y1
Du, G1

Other Studies

1 other study available for hydroxyindoleacetic acid and Carcinoma, Lewis Lung

ArticleYear
Tumor interstitial fluid promotes malignant phenotypes of lung cancer independently of angiogenesis.
    Cancer prevention research (Philadelphia, Pa.), 2015, Volume: 8, Issue:11

    Topics: Animals; Apoptosis; Aquaporin 1; Autophagy; Carcinoma, Lewis Lung; Cell Movement; Cell Proliferation

2015